2,6-diaminopurine 2',3'-dideoxyriboside and vidarabine

2,6-diaminopurine 2',3'-dideoxyriboside has been researched along with vidarabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balzarini, J; De Clercq, E	1

Other Studies

1 other study(ies) available for 2,6-diaminopurine 2',3'-dideoxyriboside and vidarabine

Article	Year
The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine. Biochemical and biophysical research communications, 1989, Feb-28, Volume: 159, Issue:1 Topics: Dideoxyadenosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Synergism; Simplexvirus; Vaccinia virus; Vidarabine; Viral Plaque Assay	1989

Article

Year

The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.

Biochemical and biophysical research communications, 1989, Feb-28, Volume: 159, Issue:1

Topics: Dideoxyadenosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Synergism; Simplexvirus; Vaccinia virus; Vidarabine; Viral Plaque Assay

1989